Specifically, the CAF-S1 subtype in BC increases recruitment and differentiation of CD4+CD25+ Tregs in TME, through CXCL12/SDF1-α leading to the inhibition of effector T cell function [108]. This evidence concerns the gene CXCL12 and breast cancer.